Jason Westin Selected Research

Jason Westin Research Topics

Disease

28	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 05/2015
17	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 01/2010
12	Neoplasms (Cancer) 01/2023 - 08/2014
8	Lymphoma (Lymphomas) 01/2023 - 05/2015
7	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2024 - 01/2016
7	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2021 - 11/2013
3	Hematologic Neoplasms (Hematological Malignancy) 11/2022 - 01/2019
3	cell-associated neurotoxicity 01/2022 - 01/2020
2	Infections 11/2022 - 01/2016
2	Cytokine Release Syndrome 01/2022 - 01/2022
2	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 01/2019
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2019 - 01/2019
1	Inflammation (Inflammations) 01/2023
1	Persistent Infection 11/2022
1	Viremia 11/2022
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2022
1	Critical Illness (Critically Ill) 01/2022
1	Disease Progression 01/2022
1	Cytopenia 10/2021
1	Long Term Adverse Effects 10/2021
1	Opportunistic Infections (Opportunistic Infection) 10/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Pancytopenia 01/2021
1	Poisoning 01/2021
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020
1	Leukemia 01/2020
1	Microsatellite Instability 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018
1	Anemia 07/2017
1	Plasmablastic Lymphoma 03/2016
1	Atrial Fibrillation 01/2016
1	Hemorrhage 01/2016
1	Lymphocytosis 01/2016

Drug/Important Bio-Agent (IBA)

15	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2018
10	axicabtagene ciloleucelIBA 03/2024 - 01/2020
10	Rituximab (Mabthera)FDA Link 01/2023 - 11/2013
7	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 11/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 11/2013
5	Vincristine (Oncovin)FDA LinkGeneric 11/2021 - 11/2013
4	ibrutinibIBA 01/2023 - 08/2014
4	Prednisone (Sone)FDA LinkGeneric 11/2021 - 08/2014
3	venetoclaxIBA 11/2021 - 01/2018
3	Etoposide (VP 16)FDA LinkGeneric 11/2021 - 05/2015
2	brexucabtagene autoleucelIBA 01/2024 - 01/2021
2	RNA (Ribonucleic Acid)IBA 11/2023 - 01/2020
2	Lenalidomide (CC 5013)FDA Link 01/2023 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2019
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
1	Small Cytoplasmic RNAIBA 11/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	PolyaminesIBA 11/2022
1	Ribavirin (Virazole)FDA LinkGeneric 11/2022
1	Antiviral Agents (Antivirals)IBA 11/2022
1	Immunoglobulin G (IgG)IBA 11/2022
1	Monoclonal AntibodiesIBA 01/2022
1	PlatinumIBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	tazemetostatIBA 01/2022
1	atezolizumabIBA 01/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	OligonucleotidesIBA 01/2022
1	PNT100IBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	tocilizumab (atlizumab)FDA Link 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 12/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2021
1	Mustard Gas (Sulfur Mustard)IBA 01/2021
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	AntigensIBA 01/2020
1	N 30IBA 01/2020
1	romidepsin (FK228)FDA Link 01/2020
1	tisagenlecleucelIBA 01/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	MLN 8237IBA 01/2020
1	Dacarbazine (DIC)FDA LinkGeneric 01/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	FM 100 (FM100)IBA 01/2019
1	fludarabineIBA 01/2019
1	Proteasome InhibitorsIBA 01/2018
1	ixazomibIBA 01/2018
1	Interferon-gamma (Interferon, gamma)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2018
1	Bortezomib (Velcade)FDA Link 01/2017
1	Cyclin D1IBA 01/2016
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 07/2015

Therapy/Procedure

26	Therapeutics 03/2024 - 01/2010
12	Radiotherapy 01/2020 - 05/2015
8	Drug Therapy (Chemotherapy) 01/2023 - 11/2013
6	Stem Cell Transplantation 01/2023 - 10/2017
3	Immunotherapy 01/2023 - 01/2018
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021
1	Homologous Transplantation 01/2019